Table 2.

Analysis of USP9X expression and clinical features in 86 laryngeal cancer paraffin specimens

Clinical features	Cases	IHC analysis of USP9X		c2	P
		High expression	Low expression
Gender
Male	84	71	13	0.664	0.415
Female	2	2	0
Age (years)
≤60	27	21	6	0.604	0.437
>60	59	52	7
Clinical stages
I-II	14	11	3	0.480	0.488
III-IV	72	62	10
Degree of differentiation
Poorly	31	29	2	6.448	0.040
Moderately	42	36	6
High	13	8	5
Lymphatic metastasis
Yes	30	28	2	2.870	0.090
No	56	45	11